Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer

Research output: Contribution to journal › Letter › peer-review

25 Scopus citations

Access to Document

@article{47f9e95ca2814a1f85377dd99ac24c5b,

title = "Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer",

author = "Chigusa Morizane and Shuichi Okada and Takuji Okusaka and Hideki Ueno and Toshimitsu Saisho",

year = "2003",

doi = "10.1159/000070310",

language = "English",

volume = "64",

pages = "475--476",

journal = "Oncology",

issn = "0030-2414",

publisher = "S. Karger AG",

number = "4",

}

TY - JOUR

T1 - Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer

AU - Morizane, Chigusa

AU - Okada, Shuichi

AU - Okusaka, Takuji

AU - Ueno, Hideki

AU - Saisho, Toshimitsu

PY - 2003

Y1 - 2003

UR - https://www.scopus.com/pages/publications/0038312231

U2 - 10.1159/000070310

DO - 10.1159/000070310

M3 - Letter

C2 - 12759549

AN - SCOPUS:0038312231

SN - 0030-2414

VL - 64

SP - 475

EP - 476

JO - Oncology

JF - Oncology

IS - 4

ER -